Innovative Diagnostic Technology CoaguSense Inc specializes in advanced point-of-care coagulation diagnostics with the Coag-Sense® system, which employs direct clot detection technology to deliver highly accurate and precise PT/INR monitoring, appealing to healthcare providers seeking reliable at-home or bedside testing solutions.

Market Expansion Potential Having been acquired by i-SENS Inc. in 2016, CoaguSense benefits from the backing of a larger organization in the diagnostic space, presenting opportunities for collaboration, distribution expansion, and increased market penetration in the medical diagnostics industry.

Growth and Revenue Opportunities With an estimated revenue range of $1 million to $10 million and a niche focus on coagulation testing, there is significant potential to grow sales by targeting clinics, hospitals, and home-care segments that require portable and accurate INR monitoring devices.

Technical and Digital Presence Utilizing modern technology stacks such as Cloudflare, Google Tag Manager, and JSON-LD indicates an online strategy aimed at visibility and customer engagement, providing a platform to reach healthcare professionals and expand digital marketing efforts.

Industry Positioning As a small but innovative company competing with industry giants like Abbott and Medtronic, CoaguSense can position itself as a specialized provider for high-precision coagulation testing, attracting buyers looking for dedicated, accurate point-of-care solutions.